mitoxantrone and Skin Neoplasms
mitoxantrone has been researched along with Skin Neoplasms in 18 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Skin Neoplasms: Tumors or cancer of the SKIN.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vinorelbine and mitoxantrone have both been demonstrated to have significant antitumor activity in patients with breast cancer." | 9.12 | Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancer. ( Aravantinos, G; Bafaloukos, D; Fountzilas, G; Gogas, H; Kalofonos, HP; Koutras, A; Makatsoris, T; Mantzourani, M; Markopoulos, C; Onyenadum, A; Tzorakoelefterakis, E; Xiros, N, 2007) |
| "1 years) and 1 male (71 years) with histologically verified metastasizing breast cancer were submitted to mitoxantrone therapy." | 7.67 | [Mitoxantrone in the primary treatment of metastasizing breast cancer]. ( Dittrich, C; Dudczak, R; Lenzhofer, R; Moser, K; Pirker, P; Rainer, H; Schuster, R, 1984) |
| "Twenty-nine patients with metastatic malignant melanoma without prior chemotherapy and 36 patients refractory to prior chemotherapy received mitoxantrone (5 mg/m2/week)." | 7.67 | Mitoxantrone in malignant melanoma. ( Bartolucci, A; Gams, R; Presant, CA, 1984) |
| "In a phase II study 20 patients with measurable metastatic melanoma were treated with amsacrine 120 mg/m2 every 3 weeks." | 7.67 | Chemotherapy in metastatic melanoma: phase II studies of amsacrine, mitoxantrone and bisantrene. ( Bishop, J; Coates, AS; Mann, GJ; Raghavan, D, 1986) |
| "Mitoxantrone (MTO) was topically applied for melanoma therapy using an MTO ethosome gel." | 5.42 | Improved anti-melanoma effect of a transdermal mitoxantrone ethosome gel. ( Du, L; Fu, G; Jin, Y; Li, Y; Yu, X, 2015) |
| "Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare lymphoma." | 5.35 | Use of fludarabine-containing chemotherapeutic regimen results in durable complete remission of subcutaneous panniculitis-like T-cell lymphoma. ( Chim, CS; Kwong, YL; Loong, F; Ng, WK, 2008) |
| "Vinorelbine and mitoxantrone have both been demonstrated to have significant antitumor activity in patients with breast cancer." | 5.12 | Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancer. ( Aravantinos, G; Bafaloukos, D; Fountzilas, G; Gogas, H; Kalofonos, HP; Koutras, A; Makatsoris, T; Mantzourani, M; Markopoulos, C; Onyenadum, A; Tzorakoelefterakis, E; Xiros, N, 2007) |
| "Transdermal delivery of mitoxantrone liposomes could be a potential therapy for cutaneous malignant melanoma." | 3.73 | [Preparation of mitoxantrone liposomes and study on its in vivo distribution in rats after transdermal delivery]. ( Chen, T; Hou, SX; Sun, YY; Zheng, Y, 2006) |
| "1 years) and 1 male (71 years) with histologically verified metastasizing breast cancer were submitted to mitoxantrone therapy." | 3.67 | [Mitoxantrone in the primary treatment of metastasizing breast cancer]. ( Dittrich, C; Dudczak, R; Lenzhofer, R; Moser, K; Pirker, P; Rainer, H; Schuster, R, 1984) |
| "Twenty-nine patients with metastatic malignant melanoma without prior chemotherapy and 36 patients refractory to prior chemotherapy received mitoxantrone (5 mg/m2/week)." | 3.67 | Mitoxantrone in malignant melanoma. ( Bartolucci, A; Gams, R; Presant, CA, 1984) |
| "In a phase II study 20 patients with measurable metastatic melanoma were treated with amsacrine 120 mg/m2 every 3 weeks." | 3.67 | Chemotherapy in metastatic melanoma: phase II studies of amsacrine, mitoxantrone and bisantrene. ( Bishop, J; Coates, AS; Mann, GJ; Raghavan, D, 1986) |
| " The affected tumors remained dormant long after dosing stopped, resulting in a prolonged progression-free survival and sustained immune surveillance of the host bearing desmoplastic melanoma." | 1.48 | Nanocarrier-Mediated Chemo-Immunotherapy Arrested Cancer Progression and Induced Tumor Dormancy in Desmoplastic Melanoma. ( Chen, F; Hou, L; Huang, L; Liu, Q; Shen, L; Wang, D; Zhang, X, 2018) |
| "Mitoxantrone (MTO) was topically applied for melanoma therapy using an MTO ethosome gel." | 1.42 | Improved anti-melanoma effect of a transdermal mitoxantrone ethosome gel. ( Du, L; Fu, G; Jin, Y; Li, Y; Yu, X, 2015) |
| "Prostate cancer is a commonly diagnosed and treated malignancy, although it rarely presents with cutaneous metastases." | 1.40 | Cutaneous metastasis of prostate carcinoma treated with radiotherapy: a case presentation. ( Chin, M; De Souza, P; Mak, G; Nahar, N, 2014) |
| "Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare lymphoma." | 1.35 | Use of fludarabine-containing chemotherapeutic regimen results in durable complete remission of subcutaneous panniculitis-like T-cell lymphoma. ( Chim, CS; Kwong, YL; Loong, F; Ng, WK, 2008) |
| "The relative increased risk of breast cancer in MS women under IS treatment warrants further attention." | 1.35 | Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis. ( Berthier, F; Clavelou, P; Danzon, A; de Seze, J; Debouverie, M; Defer, G; Gout, O; Lebrun, C; Rumbach, L; Vermersch, P; Wiertlevski, S, 2008) |
| "Subcutaneous panniculitis-like T-cell lymphoma (SCPTCL) is a rare cutaneous T-cell lymphoma." | 1.31 | Aggressive subcutaneous panniculitis-like T-cell lymphoma: complete remission with fludarabine, mitoxantrone and dexamethasone. ( Au, WY; Choy, C; Kwong, YL; Ng, WM, 2000) |
Research
Studies (18)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (16.67) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Liu, Q | 1 |
| Chen, F | 1 |
| Hou, L | 1 |
| Shen, L | 1 |
| Zhang, X | 1 |
| Wang, D | 1 |
| Huang, L | 1 |
| Mak, G | 1 |
| Chin, M | 1 |
| Nahar, N | 1 |
| De Souza, P | 1 |
| Yu, X | 1 |
| Du, L | 1 |
| Li, Y | 1 |
| Fu, G | 1 |
| Jin, Y | 1 |
| Le Coz, V | 1 |
| Zhu, C | 1 |
| Devocelle, A | 1 |
| Vazquez, A | 1 |
| Boucheix, C | 1 |
| Azzi, S | 1 |
| Gallerne, C | 1 |
| Eid, P | 1 |
| Lecourt, S | 1 |
| Giron-Michel, J | 1 |
| Chim, CS | 1 |
| Loong, F | 1 |
| Ng, WK | 1 |
| Kwong, YL | 2 |
| Adiga, GU | 1 |
| Abebe, L | 1 |
| Wiernik, PH | 1 |
| Zinzani, PL | 1 |
| Stefoni, V | 1 |
| Alinari, L | 1 |
| Vianelli, N | 1 |
| Baccarani, M | 1 |
| Chen, T | 1 |
| Hou, SX | 1 |
| Sun, YY | 1 |
| Zheng, Y | 1 |
| Isogai, R | 1 |
| Fukao, M | 1 |
| Kawada, A | 1 |
| Onyenadum, A | 1 |
| Gogas, H | 1 |
| Markopoulos, C | 1 |
| Bafaloukos, D | 1 |
| Aravantinos, G | 1 |
| Mantzourani, M | 1 |
| Koutras, A | 1 |
| Tzorakoelefterakis, E | 1 |
| Xiros, N | 1 |
| Makatsoris, T | 1 |
| Fountzilas, G | 1 |
| Kalofonos, HP | 1 |
| Lebrun, C | 1 |
| Debouverie, M | 1 |
| Vermersch, P | 1 |
| Clavelou, P | 1 |
| Rumbach, L | 1 |
| de Seze, J | 1 |
| Wiertlevski, S | 1 |
| Defer, G | 1 |
| Gout, O | 1 |
| Berthier, F | 1 |
| Danzon, A | 1 |
| Lenzhofer, R | 1 |
| Rainer, H | 1 |
| Schuster, R | 1 |
| Pirker, P | 1 |
| Dudczak, R | 1 |
| Dittrich, C | 1 |
| Moser, K | 1 |
| Presant, CA | 1 |
| Gams, R | 1 |
| Bartolucci, A | 1 |
| Uno, Y | 1 |
| Momoi, Y | 1 |
| Watari, T | 1 |
| Goitsuka, R | 1 |
| Tsujimoto, H | 1 |
| Shimada, T | 1 |
| Ono, K | 1 |
| Goto, N | 1 |
| Hasegawa, A | 1 |
| Yokoe, T | 1 |
| Iino, Y | 1 |
| Aoyagi, H | 1 |
| Maemura, M | 1 |
| Sugamata, N | 1 |
| Takai, Y | 1 |
| Horiguchi, J | 1 |
| Ishida, T | 1 |
| Morishita, Y | 1 |
| Doi, T | 1 |
| Sakamaki, S | 1 |
| Koike, K | 1 |
| Matsunaga, T | 1 |
| Kobayashi, D | 1 |
| Muramatsu, H | 1 |
| Sato, T | 1 |
| Watanabe, N | 1 |
| Kougo, Y | 1 |
| Niitsu, Y | 1 |
| Au, WY | 1 |
| Ng, WM | 1 |
| Choy, C | 1 |
| Coates, AS | 1 |
| Bishop, J | 1 |
| Mann, GJ | 1 |
| Raghavan, D | 1 |
Reviews
1 review available for mitoxantrone and Skin Neoplasms
| Article | Year |
|---|---|
Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bowen's Disease; Co | 2003 |
Trials
1 trial available for mitoxantrone and Skin Neoplasms
| Article | Year |
|---|---|
Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brai | 2007 |
Other Studies
16 other studies available for mitoxantrone and Skin Neoplasms
| Article | Year |
|---|---|
Nanocarrier-Mediated Chemo-Immunotherapy Arrested Cancer Progression and Induced Tumor Dormancy in Desmoplastic Melanoma.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Proliferation; Disease Progressio | 2018 |
Cutaneous metastasis of prostate carcinoma treated with radiotherapy: a case presentation.
Topics: Aged; Humans; Male; Mitoxantrone; Prednisolone; Prostatic Neoplasms; Skin Neoplasms | 2014 |
Improved anti-melanoma effect of a transdermal mitoxantrone ethosome gel.
Topics: Administration, Cutaneous; Animals; Antineoplastic Agents; Gels; Male; Melanoma; Mice; Mice, Inbred | 2015 |
IGF-1 contributes to the expansion of melanoma-initiating cells through an epithelial-mesenchymal transition process.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferati | 2016 |
Use of fludarabine-containing chemotherapeutic regimen results in durable complete remission of subcutaneous panniculitis-like T-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Female; Humans; Lymphoma, T-Ce | 2008 |
Rituximab in heavily pretreated cutaneous B-cell lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; | 2003 |
[Preparation of mitoxantrone liposomes and study on its in vivo distribution in rats after transdermal delivery].
Topics: Administration, Cutaneous; Animals; Antineoplastic Agents; Female; Liposomes; Melanoma; Microscopy, | 2006 |
Successful treatment for recurrence of primary cutaneous anaplastic large-cell lymphoma in elderly patient with etoposide, mitoxantrone, cyclophosphamide, vincristine, prednisolone and bleomycin (VNCOP-B) therapy.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxo | 2007 |
Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis.
Topics: Adult; Azathioprine; Breast Neoplasms; Central Nervous System Neoplasms; Cyclophosphamide; Digestive | 2008 |
[Mitoxantrone in the primary treatment of metastasizing breast cancer].
Topics: Aged; Alopecia; Anthraquinones; Brain Neoplasms; Breast Neoplasms; Drug Tolerance; Electrocardiograp | 1984 |
Mitoxantrone in malignant melanoma.
Topics: Anthraquinones; Antineoplastic Agents; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; | 1984 |
Malignant histiocytosis with multiple skin lesions in a dog.
Topics: Animals; Antigens, Neoplasm; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Cycl | 1993 |
[Combined mitoxantrone therapy for heavily pretreated metastatic breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Doxor | 1993 |
[CD7, HLA-DR, CD38 positive acute undifferentiated leukemia with subcutaneous tumor and thymoma].
Topics: Acute Disease; ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Antigens, CD; Antigens, CD7; Antigens, Di | 1996 |
Aggressive subcutaneous panniculitis-like T-cell lymphoma: complete remission with fludarabine, mitoxantrone and dexamethasone.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Female; Follow-Up Studies; Hum | 2000 |
Chemotherapy in metastatic melanoma: phase II studies of amsacrine, mitoxantrone and bisantrene.
Topics: Aminoacridines; Amsacrine; Anthracenes; Anthraquinones; Antineoplastic Agents; Drug Evaluation; Fema | 1986 |